WuXi XDC Cayman (FRA:L74) Equity-to-Asset : 0.62 (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. WuXi XDC Cayman's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €218.9 Mil. WuXi XDC Cayman's Total Assets for the quarter that ended in Jun. 2023 was €353.1 Mil. Therefore, WuXi XDC Cayman's Equity to Asset Ratio for the quarter that ended in Jun. 2023 was 0.62.

The historical rank and industry rank for WuXi XDC Cayman's Equity-to-Asset or its related term are showing as below:

FRA:L74' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.02 Med: 0.7 Max: 0.92
Current: 0.81

During the past 4 years, the highest Equity to Asset Ratio of WuXi XDC Cayman was 0.92. The lowest was 0.02. And the median was 0.70.

FRA:L74's Equity-to-Asset is ranked better than
85.23% of 237 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs FRA:L74: 0.81

WuXi XDC Cayman Equity-to-Asset Historical Data

The historical data trend for WuXi XDC Cayman's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Equity-to-Asset Chart

WuXi XDC Cayman Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

0.92

0.02

0.59

0.81

WuXi XDC Cayman Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			-	0.59	0.61	0.62	0.81

Competitive Comparison of WuXi XDC Cayman's Equity-to-Asset

For the Diagnostics & Research subindustry, WuXi XDC Cayman's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi XDC Cayman's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's Equity-to-Asset falls into.

WuXi XDC Cayman Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

WuXi XDC Cayman's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	700.486	/	865.002
	=	0.81

WuXi XDC Cayman's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	218.927	/	353.14
	=	0.62

WuXi XDC Cayman (FRA:L74) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

WuXi XDC Cayman Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman (FRA:L74) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (FRA:L74) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

02268:Hong Kong

Address

No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN

Website

WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman (FRA:L74) Headlines

No Headlines